Karen Morris
Leidos (United States)(US)Frederick National Laboratory for Cancer Research(US)National Cancer Institute(US)Center for Cancer Research(US)
Publications by Year
Research Areas
Cancer Cells and Metastasis, Lung Cancer Research Studies, Cancer, Hypoxia, and Metabolism, Neuroendocrine Tumor Research Advances, Cancer Genomics and Diagnostics
Most-Cited Works
- → Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer(2012)837 cited
- → Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer(2014)688 cited
- → Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer(2016)300 cited
- → Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial(2015)277 cited
- → A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer(2023)191 cited
- → Tumor stroma–targeted antibody-drug conjugate triggers localized anticancer drug release(2018)